|
시장보고서
상품코드
1559255
백신 연구 시장(2024-2028년)Global Vaccine Research Market 2024-2028 |
||||||
백신 연구 시장은 2023-2028년간 214억 달러 확대되고, 예측 기간 동안 10.84%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
본 보고서는 백신 연구 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등을 수록했습니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 감염성 질환의 높은 유병률, 만성 감염성 질환에 대한 새로운 백신에 대한 수요, 보조제 및 백신 전달 시스템에 의해 주도되고 있습니다.
| 시장 범위 | |
|---|---|
| 기준년도 | 2024년 |
| 종료년도 | 2028년 |
| 예측 기간 | 2024-2028년 |
| 성장 모멘텀 | 가속 |
| 2024년 전년 대비 | 9.43% |
| CAGR | 10.84% |
| 증분 금액 | 214억 달러 |
이 보고서는 향후 몇 년동안 백신 연구 시장의 성장을 가속할 주요 요인 중 하나로 백신 연구 및 개발을 가속화하기 위한 AI의 채택을 꼽았습니다. 또한, 고소득 국가와 신흥국의 백신 수요 변동과 새로운 백신 연구 및 개발 증가는 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
- 시장 개요
제2장 시장 구도
- 시장 생태계
- 시장 특징
- 밸류체인 분석
제3장 시장 규모 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2023년)
- 시장 전망(2023-2028년)
제4장 시장 규모 실적
- 세계의 백신 연구 시장(2018-2022년)
- 최종사용자별 부문 분석(2018-2022년)
- 연령층별 부문 분석(2018-2022년)
- 지역별 부문 분석(2018-2022년)
- 국가별 부문 분석(2018-2022년)
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제6장 시장 세분화 : 최종사용자별
- 시장 세분화
- 비교 : 최종사용자별
- 공공 : 시장 규모와 예측(2023-2028년)
- 민간 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 최종사용자별
제7장 시장 세분화 : 연령층별
- 시장 세분화
- 비교 : 연령층별
- 소아 : 시장 규모와 예측(2023-2028년)
- 성인 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 연령층별
제8장 고객 상황
- 고객 상황 개요
제9장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2023-2028년)
- 유럽 : 시장 규모와 예측(2023-2028년)
- 아시아 : 시장 규모와 예측(2023-2028년)
- 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
- 미국 : 시장 규모와 예측(2023-2028년)
- 독일 : 시장 규모와 예측(2023-2028년)
- 영국 : 시장 규모와 예측(2023-2028년)
- 중국 : 시장 규모와 예측(2023-2028년)
- 캐나다 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 지역 상황별
제10장 성장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회, 성장 억제요인
제11장 경쟁 구도
- 개요
- 경쟁 구도
- 혼란 상황
- 업계 리스크
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Abbott Laboratories
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bavarian Nordic AS
- Bharat Biotech Ltd.
- CanSino Biologics Inc.
- CSL Ltd.
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Merck and Co. Inc.
- Novavax Inc.
- Panacea Biotec Ltd.
- Pfizer Inc.
제13장 부록
LSH 24.10.22The vaccine research market is forecasted to grow by USD 21.4 bn during 2023-2028, accelerating at a CAGR of 10.84% during the forecast period. The report on the vaccine research market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of infectious diseases, need for novel vaccines for chronic infections, and adjuvants and vaccine delivery systems.
Technavio's vaccine research market is segmented as below:
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 9.43% |
| CAGR | 10.84% |
| Incremental Value | $21.4 bn |
By End-user
- Public
- Private
By Age Group
- Pediatric
- Adult
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the adoption of ai to speed up r and d of vaccines as one of the prime reasons driving the vaccine research market growth during the next few years. Also, fluctuations in demand for vaccines in high-income and developing countries and rising r and d of novel vaccines will lead to sizable demand in the market.
The report on the vaccine research market covers the following areas:
- Vaccine research market sizing
- Vaccine research market forecast
- Vaccine research market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccine research market vendors that include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., Creative Biogene, CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd.. Also, the vaccine research market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Vaccine Research Market 2018 - 2022
- Historic Market Size - Data Table on Global Vaccine Research Market 2018 - 2022 ($ billion)
- 4.2 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
- 4.3 Age Group segment analysis 2018 - 2022
- Historic Market Size - Age Group Segment 2018 - 2022 ($ billion)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
- 6.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
- 6.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 6.3 Public - Market size and forecast 2023-2028
- Chart on Public - Market size and forecast 2023-2028 ($ billion)
- Data Table on Public - Market size and forecast 2023-2028 ($ billion)
- Chart on Public - Year-over-year growth 2023-2028 (%)
- Data Table on Public - Year-over-year growth 2023-2028 (%)
- 6.4 Private - Market size and forecast 2023-2028
- Chart on Private - Market size and forecast 2023-2028 ($ billion)
- Data Table on Private - Market size and forecast 2023-2028 ($ billion)
- Chart on Private - Year-over-year growth 2023-2028 (%)
- Data Table on Private - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Age Group
- 7.1 Market segments
- Chart on Age Group - Market share 2023-2028 (%)
- Data Table on Age Group - Market share 2023-2028 (%)
- 7.2 Comparison by Age Group
- Chart on Comparison by Age Group
- Data Table on Comparison by Age Group
- 7.3 Pediatric - Market size and forecast 2023-2028
- Chart on Pediatric - Market size and forecast 2023-2028 ($ billion)
- Data Table on Pediatric - Market size and forecast 2023-2028 ($ billion)
- Chart on Pediatric - Year-over-year growth 2023-2028 (%)
- Data Table on Pediatric - Year-over-year growth 2023-2028 (%)
- 7.4 Adult - Market size and forecast 2023-2028
- Chart on Adult - Market size and forecast 2023-2028 ($ billion)
- Data Table on Adult - Market size and forecast 2023-2028 ($ billion)
- Chart on Adult - Year-over-year growth 2023-2028 (%)
- Data Table on Adult - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Age Group
- Market opportunity by Age Group ($ billion)
- Data Table on Market opportunity by Age Group ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- Companies covered
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- 12.4 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
- 12.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 12.6 Bavarian Nordic AS
- Bavarian Nordic AS - Overview
- Bavarian Nordic AS - Product / Service
- Bavarian Nordic AS - Key news
- Bavarian Nordic AS - Key offerings
- 12.7 Bharat Biotech Ltd.
- Bharat Biotech Ltd. - Overview
- Bharat Biotech Ltd. - Product / Service
- Bharat Biotech Ltd. - Key offerings
- 12.8 CanSino Biologics Inc.
- CanSino Biologics Inc. - Overview
- CanSino Biologics Inc. - Product / Service
- CanSino Biologics Inc. - Key news
- CanSino Biologics Inc. - Key offerings
- 12.9 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- 12.10 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key news
- Daiichi Sankyo Co. Ltd. - Key offerings
- 12.11 Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. - Overview
- Emergent BioSolutions Inc. - Product / Service
- Emergent BioSolutions Inc. - Key offerings
- 12.12 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- 12.13 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- 12.14 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- 12.15 Novavax Inc.
- Novavax Inc. - Overview
- Novavax Inc. - Product / Service
- Novavax Inc. - Key offerings
- 12.16 Panacea Biotec Ltd.
- Panacea Biotec Ltd. - Overview
- Panacea Biotec Ltd. - Product / Service
- Panacea Biotec Ltd. - Key news
- Panacea Biotec Ltd. - Key offerings
- 12.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- Research methodology
- 13.5 Data procurement
- Information sources
- 13.6 Data validation
- Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- Data synthesis
- 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
- List of abbreviations
